Corvus Pharmaceuticals, Inc. (CRVS) vs Ginkgo Bioworks Holdings, Inc. (DNA)

• Corvus Pharmaceuticals, Inc. CRVS 9.52 ▼ −3.35%
• Ginkgo Bioworks Holdings, Inc. DNA 10.27 ▼ −12.67%

Corvus Pharmaceuticals, Inc. and Ginkgo Bioworks Holdings, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Ginkgo Bioworks Holdings, Inc. are of similar size ($828.6M and $791.9M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −219.6%) and the lower return on invested capital (−352.5% vs −161.9%). Across the 13 metrics below, Corvus Pharmaceuticals, Inc. leads on 10 and Ginkgo Bioworks Holdings, Inc. on 3.